🇺🇸 FDA
Patent

US 10668050

Compositions, methods and kits for treating diarrhea-predominant irritable bowel syndrome

granted A61KA61K31/4178A61K9/2013

Quick answer

US patent 10668050 (Compositions, methods and kits for treating diarrhea-predominant irritable bowel syndrome) held by RedHill Biopharma Ltd. expires Mon May 28 2040 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
RedHill Biopharma Ltd.
Grant date
Tue Jun 02 2020 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon May 28 2040 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
5
CPC classes
A61K, A61K31/4178, A61K9/2013, A61K9/2054, A61K9/2077